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Guidelines recommend primary care physicians (PCPs) offer patients a choice of colorectal 38 
cancer (CRC) screening methods, including colonoscopy and fecal occult blood tests (FOBT).(1) 39 
However, in countries like the US and Switzerland, patients are screened almost exclusively 40 
with colonoscopy.(2, 3) When offered both tests, patients appear as likely to choose one as 41 
the other; the predominance of colonoscopy may largely be explained by physician preference 42 
and local medical culture.(4) Offering only colonoscopy might explain why screening rates are 43 
low. 44 
We sought to determine the proportions of patients who opted for screening with 45 
colonoscopy or FOBT and who refused testing among 50-75-year-olds eligible for screening at 46 
a PCP visit. We described variation in care between PCPs and tried to identify PCP-level factors 47 
associated with testing method and refusal. 48 
Methods 49 
We conducted a cross-sectional data collection on CRC screening practices at PCP-level. We 50 
invited 129 PCPs from the Swiss Sentinel Surveillance Network (Sentinella) to fill a structured 51 
data collection form for 40 consecutive non-emergent consultations with 50-75-year-old 52 
patients. The federal office of public health (FOPH) provided demographic data at PCP level. 53 
PCPs reported demographic data at patient-level, data on previous CRC tests, contra-54 
indications for screening, risk factors for CRC, if CRC screening was discussed, choice of test 55 
(colonoscopy, FOBT, other), and refusal for testing. We calculated overall proportions and 56 
reported variation between PCPs in the proportion of FOBT vs. colonoscopy they prescribed 57 
to patients who chose to be tested. We calculated overall prescription rates of FOBT vs. 58 
colonoscopy for each PCP, including both patients who had already undergone screening and 59 
patients prescribed screening after the consultation. We dichotomized this covariate by 60 
never-prescription of FOBT (no patients previously tested with FOBT or prescribed FOBT after 61 
discussion) vs. any FOBT.  62 
We used mixed-effects logistic regression models that allowed us to cluster the data by PCP 63 
(with PCPs modeled as a random effect) to explore the association between PCP 64 
characteristics and the proportion of patients who refused screening after discussion. We 65 
adjusted the models for PCPs’ demographics (age, sex) and language region, for patients’ 66 





91 PCPs (71% of invited, mean age:54, 24% women) collected data on 3,637 patients. 186 70 
patients were excluded because they were not aged 50-75 y.o. or had already been seen 71 
during data collection. 3,453 patients were included in the analysis (mean age:63, 50% 72 
women). PCPs discussed screening with 51% (874/1727) of eligible patients (not up-to-date 73 
and no contra-indications for testing) (Figure 1). After excluding patients with risk factors or 74 
symptoms suggestive of CRC (n=104), 61% (473/770) opted for screening (FOBT/colonoscopy 75 
ratio:0.5), 29% refused, 6% were undecided and 3% were unspecified or missing. Most 76 
patients who refused screening said they did so because they didn’t feel concerned. 77 
33 PCPs (36%) had none of their patients previously tested with FOBT or who planned to be 78 
tested with FOBT. Patients of PCPs who only offered colonoscopy were more likely to refuse 79 
screening than patients of PCPs who offered both colonoscopy and FOBT (44%vs.20%, 80 
respectively, Figure 2). These results were confirmed in our mixed-effects multivariate model 81 
(OR:3.90,95%CI:1.90 to 8.00,p<0.001). No other PCPs characteristics were associated with 82 
chosen testing methods or refusal rates. 83 
Discussion 84 
When PCPs discussed CRC screening with their 50-75-year-old patients who were not up-to-85 
date with screening, had no contraindication and no risk factors for CRC, a third of their 86 
patients declined to be screened. PCPs who only offered colonoscopy had lower screening 87 
rates (47% vs. 71%) and higher refusal rates (44% vs. 20%) than PCPs who offered both 88 
colonoscopy and FOBT. These results are in line with a randomized controlled trial showing 89 
lower uptake rates of CRC screening tests among patients who are offered only colonoscopy 90 
vs. among the ones who are offered both FOBT and colonoscopy (5). We were inherently 91 
limited in considering additional patient-level sociodemographic factors by the simplicity and 92 
anonymity of our data collection. 93 
Encouraging PCPs to offer both methods could reduce the number of physicians who only 94 
prescribe one screening modality, reduce variation between practices, and allow more 95 
patients to choose the test that matches their preferences and values.(4, 6) This could reduce 96 
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Figure legends 161 
Figure 1- Flowchart of 40 consecutive patients aged 50-75 included by PCPs from the 162 
Sentinella network from in 2017.* 163 
* PCPs collected data on 40 consecutive patients aged 50-75 from on past screening status, 164 
contraindications for screening, if a discussion on CRC screening could take place, RF and 165 
symptoms for CRC and the decision taken (refusal, FOBT, colonoscopy, other). Data collected 166 
between April and December 2017. a RF = Risk factor for CRC 167 
 168 
Figure 2 – Decision patterns among patients who had a discussion on CRC screening (N 169 
patients=770) and included by PCPs who only prescribed colonoscopy (N=33) vs PCPs who 170 
prescribed both colonoscopy and FOBT (N=58), in the Sentinella Network in 2017* 171 
* Patients with risk factors or symptoms suggestive for CRC (n=104) (see Figure 1) excluded 172 
of this analysis 173 
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